PACTR202306581858623招募中Unknown
A randomized controlled trial of elective induction at 40 weeks and 41 weeks to prevent prolonged pregnancy.
IPINNIMO OLUWADARE MARTINS0 个研究点目标入组 322 人开始时间: 2023年6月10日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 322
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- Female
入选标准
- •1. Singleton pregnancies
- •2. Cephalic fetal presentation
- •3. Gestational age of 40 weeks to 41 weeks and 3 days gestation from the first day of the last menstrual period and ultrasound biometry before the 12th week of gestation.
- •4. Patients who gave consent to participate in the study.
- •5. Parity of = to 4.
排除标准
- •1. Multiple gestations.
- •2. Non cephalic presentation
- •3. Intrauterine fetal death.
- •4. Previous caesarean section scar.
- •5. Multiparous of 5 and above
- •6. Medical conditions in pregnancy e.g hypertension, diabetes mellitus and sickle cell anemia.
- •7. Pregnancies with fetuses having ultrasound diagnosed congenital abnormalities.
- •8. Women who had no early ultrasound scan report before 12th weeks
- •9. Women who declined consent.
研究者
相似试验
招募中
不适用
Randomized controlled trial of induction therapy for thoracic esophageal cancer invading aorta or trahceathoracic esophageal cancerJPRN-UMIN000014718Osaka Medical Center for Cancer and Cardiovascular Diseases160
尚未招募
4 期
A Randomized Controlled Trial on Induction of Labor using Foley Catheter and Oral MisoprostolCTRI/2020/01/022815Department of OBG
已完成
2 期
A prospective randomized controlled trial of selective conventional TACE vs. balloon occluded TACE with epirubicin for hepatocellular carcinomaJPRN-UMIN000026897agoya University Hospital Department of Gastroenterology and Hepatology164
已完成
2 期
A prospective randomized controlled trial of selective DEB-epiDOX vs. selective conventional TACE for hepatocellular carcinoma focusing on local complete response ratePatients with hepatocellular carcinoma who are scheduled to receive selective TACEJPRN-UMIN000021250Japan Interventional Radiology In Oncology Study Group(JIVROSG)440
已完成
2 期
A prospective randomized controlled trial of selective conventional TACE vs. drug-eluting beads TACE with epirubicin for patients with hepatocellular carcinomaPatients with hepatocellular carcinoma who are scheduled to underwent TACEJPRN-UMIN000030822agoya University Hospital Department of Gastroenterology and Hepatology140